BD, CerTest launch monkeypox diagnostics for laboratory research

0
The BD Max System. [Image from BD]

BD (NYSE:BDX) and CerTest Biotec announced today that they have made their monkeypox virus diagnostic commercially available.

The newly developed monkeypox molecular polymerase chain reaction (PCR) test has been made available outside the United States for use in research applications by laboratories.

Franklin Lakes, New Jersey-based BD and Zaragoza, Spain-based CerTest announced a partnership to develop the test last month, following the CDC’s announcement Chasing a monkeypox outbreak in the United States and other countries that do not typically report cases of the contagious virus. Thought to cause a rash and lesions, monkeypox is primarily shared through direct physical contact, although the CDC warns that with prolonged face-to-face contact, it can also be transmitted via respiratory secretions.

According to a press release, the new assay leveraged the BD Max open system system reagent suite to develop the CerTest Viasure monkeypox molecular test.

“One of the key advantages of the BD Max system is its open architecture, which enables rapid response to emerging health threats,” BD VP of Molecular Diagnostics Nikos Pavlidis said in release. “Just like at the beginning of the COVID-19 pandemic, we have partnered with CerTest to rapidly develop a molecular test that will help better understand and track this disease.”

A fully integrated, automated platform, BD Max performs nucleic acid extraction and real-time PCR, providing results for up to 24 samples across multiple syndromes in less than three hours. The BD Max Monkeypox PCR Detection Kit is offered in a lyophilized format, with the test supplied in a vial that snaps into the test-specific position on the BD Max ExK TNA Extraction Strip supplied by BD.

“Speed ​​is of the essence in responding to what the World Health Organization has declared a global health emergency,” he said Nelson Fernandes, Managing Director of CerTest Biotec. “We hope that this new test will increase the capacity for monkeypox research and ultimately help limit the spread of the disease.”

Share.

Comments are closed.